Search Within

Neeta Pandit-Taskar

  1. "Neuroblastoma Service"
Formats
  1. Meeting Abstract (35)
  2. Journal Article (26)
Groups
  1. Molecular Imaging and Therapy Service (61)
  2. Neuroblastoma Service (61)
  3. Pediatrics, Department of (61)
  4. Radiology, Department of (61)
  5. GSK Faculty (50)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (48)

More Groups

People
  1. Nai-Kong Cheung (48)
  2. Pat Zanzonico (44)
  3. Shakeel Modak (41)
  4. Kim Kramer (40)
  5. Steven Larson (31)
  6. John Humm (28)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (5)
  4. 2022 (7)
  5. 2021 (2)
  6. 2020 (2)

More Years

Publications
  1. Pediatric Blood and Cancer (16)
  2. Neuro-Oncology (13)
  3. Journal of Clinical Oncology (10)
  4. Journal of Nuclear Medicine (7)
  5. Journal of Neuro-Oncology (4)
  6. Cancer Research (1)

More Publications

Publishers
  1. Wiley Periodicals, Inc (16)
  2. Oxford University Press (13)
  3. American Society of Clinical Oncology (10)
  4. Society of Nuclear Medicine (7)
  5. Springer (7)
  6. Lippincott Williams & Wilkins (3)

More Publishers

Results (61)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Results of "HITS" phase II study
    Meeting Abstract

    Modak, S.; Kushner, B. H.; Mauguen, A.; Castañeda, A.; Varo, A.; Gorostegui, M.; Muñoz, J. P.; Santa-Maria, V.; Basu, E. M.; Cardenas, F. I.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase 1 study of intraventricular (131)I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies
    Journal Article

    Kramer, K.; Pandit-Taskar, N.; Kushner, B. H.; Zanzonico, P.; Humm, J. L.; Tomlinson, U.; Donzelli, M.; Wolden, S. L.; Haque, S.; Dunkel, I.; more...
    Journal of Hematology & Oncology (2022)

    Fulltext@MSK | Save
  • Long-term survival from a phase 1 doseescalation trial using convection-enhanced delivery (CED) of radioimmunotherapeutic (124)I-omburtamab for treatment of diffuse intrinsic pontine glioma (DIPG)
    Meeting Abstract

    Souweidane, M. M.; Kramer, K.; Pandit-Tasker, N.; Haque, S.; Zanzonico, P.; Carrasquillo, J.; Lyashchenko, S. K.; Thakur, S. B.; Khakoo, Y.; Dunkel, I. J.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Biodistribution and radiation dosimetry of intraperitoneally administered (124)I-omburtamab in patients with desmoplastic small round cell tumors
    Journal Article

    Grkovski, M.; Modak, S.; Zanzonico, P. B.; Carrasquillo, J. A.; Larson, S. M.; Humm, J. L.; Pandit-Taskar, N.
    Journal of Nuclear Medicine (2022)

    Fulltext@MSK | Save
  • Intraperitoneal pretargeted radioimmunotherapy for colorectal peritoneal carcinomatosis
    Journal Article

    Chandler, C. S.; Bell, M. M.; Chung, S. K.; Veach, D. R.; Fung, E. K.; Punzalan, B.; Burnes Vargas, D.; Patel, M.; Xu, H.; Guo, H. F.; more...
    Molecular Cancer Therapeutics (2022)

    Fulltext@MSK | Save
  • Phase 1 dose-escalation trial using convection-enhanced delivery of radiolabeled monoclonal antibody for diffuse intrinsic pontine glioma following external radiation therapy
    Meeting Abstract

    Souweidane, M. M.; Kramer, K.; Pandit-Taskar, N.; Haque, S.; Zanzonico, P.; Carrasquillo, J. A.; Lyashchenko, S. K.; Thakur, S. B.; Khakoo, Y.; Donzelli, M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • IntraOmmaya compartmental radioimmunotherapy using (131)I-omburtamab-pharmacokinetic modeling to optimize therapeutic index
    Journal Article

    Yerrabelli, R. S.; He, P.; Fung, E. K.; Kramer, K.; Zanzonico, P. B.; Humm, J. L.; Guo, H.; Pandit-Taskar, N.; Larson, S. M.; Cheung, N. K. V.
    European Journal of Nuclear Medicine and Molecular Imaging (2021)

    Fulltext@MSK | Save
  • B7H3-directed intraperitoneal radioimmunotherapy with radioiodinated omburtamab for desmoplastic small round cell tumor and other peritoneal tumors: Results of a phase I study
    Journal Article

    Modak, S.; Zanzonico, P.; Grkovski, M.; Slotkin, E. K.; Carrasquillo, J. A.; Lyashchenko, S. K.; Lewis, J. S.; Cheung, I. Y.; Heaton, T.; LaQuaglia, M. P.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor (GM-CSF) for Resistant Osteomedullary Neuroblastoma: Major Responses and Outpatient Treatment in a Phase II Trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Biodistribution and dosimetry of intraventricularly administered (124)I-omburtamab in patients with metastatic leptomeningeal tumors
    Journal Article

    Pandit-Taskar, N.; Zanzonico, P. B.; Kramer, K.; Grkovski, M.; Fung, E. K.; Shi, W.; Zhang, Z.; Lyashchenko, S. K.; Fung, A. M.; Pentlow, K. S.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save